These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 6409443)

  • 21. Anticarcinogenic and cocarcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons.
    DiGiovanni J; Rymer J; Slaga TJ; Boutwell RK
    Carcinogenesis; 1982; 3(4):371-5. PubMed ID: 6284398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the tumor-initiating ability of the potent carcinogen 7,12-dimethylbenz(a)anthracene by the weak tumor initiator 1,2,3,4-dibenzanthracene.
    Slaga TJ; Boutwell RK
    Cancer Res; 1977 Jan; 37(1):128-33. PubMed ID: 401469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter independence as a feature of most skin papillomas in SENCAR mice.
    Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
    Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
    Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
    Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separation of initiating and promoting effects of the skin carcinogen 7-bromomethylbenz(a)anthracene.
    Scribner NK; Scribner JD
    Carcinogenesis; 1980 Jan; 1(1):97-100. PubMed ID: 22282986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7,12-Dimethylbenz[a]anthracene inhibition of steroid production in MA-10 mouse Leydig tumor cells is not directly linked to induction of CYP1B1.
    Mandal PK; McDaniel LR; Prough RA; Clark BJ
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):200-8. PubMed ID: 11559018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of tumor-promoting ability of certain environmental chemicals in a two-stage mouse skin tumorigenesis assay.
    Berry DL; DiGiovanni J; Juchau MR; Bracken WM; Gleason GL; Slaga TJ
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):101-8. PubMed ID: 208126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent inhibitory effects of suicide inhibitors of P450 isozymes on 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene initiated skin tumors.
    Alworth WL; Viaje A; Sandoval A; Warren BS; Slaga TJ
    Carcinogenesis; 1991 Jul; 12(7):1209-15. PubMed ID: 1906378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
    DiGiovanni J; Walker SE; Aldaz CM; Slaga TJ; Conti CJ
    Carcinogenesis; 1993 Sep; 14(9):1831-6. PubMed ID: 8403206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice.
    Slaga TJ
    Environ Health Perspect; 1986 Sep; 68():27-32. PubMed ID: 3096709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential carcinogenic effects of intraperitoneal initiation with 7,12-dimethylbenz(a)anthracene or urethane and topical promotion with 12-O-tetradecanoylphorbol-13-acetate in skin and internal tissues of female SENCAR and BALB/c mice.
    Ward JM; Rehm S; Devor D; Hennings H; Wenk ML
    Environ Health Perspect; 1986 Sep; 68():61-8. PubMed ID: 3096710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse skin tumor initiating activity of fluorinated derivatives of 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene.
    Nair RV; Walker SE; Sharma PK; Witiak DT; DiGiovanni J
    Chem Res Toxicol; 1992; 5(2):153-6. PubMed ID: 1643244
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz(a)anthracene.
    Huberman E; Slaga TJ
    Cancer Res; 1979 Feb; 39(2 Pt 1):411-4. PubMed ID: 104789
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of steric strain in the bay-region of polycyclic aromatic hydrocarbons: tumorigenicity of alkyl-substituted benz[a]anthracenes.
    Levin W; Wood AW; Chang RL; Newman MS; Thakker DR; Conney AH; Jerina DM
    Cancer Lett; 1983 Sep; 20(2):139-46. PubMed ID: 6421476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
    Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
    J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exceptional tumor-initiating activity of 4-fluorobenzo[j]-fluoranthene on mouse skin: comparison with benzo[j]-fluoranthene, 10-fluoro-benzo[j]fluoranthene, benzo[a]pyrene, dibenzo[a,l]pyrene and 7,12-dimethylbenz[a]anthracene.
    LaVoie EJ; He ZM; Meegalla RL; Weyand EH
    Cancer Lett; 1993 Jun; 70(1-2):7-14. PubMed ID: 8330304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice.
    Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH
    Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carcinogenic effect of 7,12-dimethylbenz(a)anthracene 5,6-oxide in mice].
    Chouroulinkov I; Gentil A; Lasne C
    C R Acad Hebd Seances Acad Sci D; 1975 Jul; 281(2-3):207-10. PubMed ID: 809205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression.
    Stern MC; Gimenez-Conti IB; Budunova I; Coghlan L; Fischer SM; DiGiovanni J; Slaga TJ; Conti CJ
    Carcinogenesis; 1998 Jan; 19(1):125-32. PubMed ID: 9472703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.